NCT06519006 Effectiveness of Pelvic Floor Exercise to Prevent LARS (Low Anterior Resection Syndrome)
| NCT ID | NCT06519006 |
| Status | Recruiting |
| Phase | — |
| Sponsor | F. D. Roosevelt University Hospital |
| Condition | Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-04-01 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main aim of this randomized study will be to determine the effectiveness of pelvic floor exercises on the incidence or severity of LAR syndrome in patients after mini-invasive rectal resection. The main questions it aims to answer are: * Does pelvic floor exercise after low anterior resection prevent LARS (low anterior resection syndrome)? * What is the adherence of patients to prescribed home exercise after surgery? * Quality of life after LAR Researchers will compare the group of patients with pelvic floor exercises to those without and determine the occurrence and severity of LARS. Participants will: * under the professional guidance of a physiotherapist, the day before surgery and in the first 4 postoperative days be educated to exercise the pelvic floor * continue exercise at home for a month (according to the instructions together with the infographic)
Eligibility Criteria
Inclusion Criteria: * Cognitive functions make it possible to understand and sign the patient\'s informed consent and consent to participate in the study * Surgical procedure - mini-invasive low anterior rectal resection Exclusion Criteria: * not agreeing to participate in the study * request to practice pelvic floor exercises despite being in the control group * non-compliance * serious psychiatric diagnoses
Contact & Investigator
Ľubomír Marko, MD,ass. prof
STUDY DIRECTOR
F. D. Roosevelt University Hospital
Frequently Asked Questions
Who can join the NCT06519006 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06519006 currently recruiting?
Yes, NCT06519006 is actively recruiting participants. Contact the research team at barbara.mrazova19@gmail.com for enrollment information.
Where is the NCT06519006 trial being conducted?
This trial is being conducted at Banská Bystrica, Slovakia.
Who is sponsoring the NCT06519006 clinical trial?
NCT06519006 is sponsored by F. D. Roosevelt University Hospital. The principal investigator is Ľubomír Marko, MD,ass. prof at F. D. Roosevelt University Hospital. The trial plans to enroll 50 participants.